CureVac N.V. logo
CureVac N.V. CVAC

Quarterly report 2022-Q2
added 08-18-2022

report update icon

CureVac N.V. Income Statement 2011-2026 | CVAC

Annual Income Statement CureVac N.V.

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

3.53 B 16.2 B - - - - - - - - -

Shares

186 M 181 M - - - - - - - - -

Historical Prices

19.3 89.3 - - - - - - - - -

Net Income

-412 M -130 M -99.9 M -71.2 M - - - - - - -

Revenue

- 48.9 M 17.4 M 12.9 M - - - - - - -

Cost of Revenue

238 M 14.2 M 28 M 17.7 M - - - - - - -

Gross Profit

- - -10.6 M -4.87 M - - - - - - -

Operating Income

-412 M -110 M -99.5 M -72.8 M - - - - - - -

EBITDA

-412 M -99.1 M -97.3 M -71.2 M - - - - - - -

Operating Expenses

- - 88.9 M 68 M - - - - - - -

General and Administrative Expenses

100 M - 42.2 M 20.4 M - - - - - - -

All numbers in EUR currency

Quarterly Income Statement CureVac N.V.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - 187 M - - - 184 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- - - -15.1 M - - - -114 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - 37.2 M - - - 15.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - -15.3 M - - - -116 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - -15.3 M - - - -116 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- - - 24.6 M - - - 21.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in EUR currency

The income statement is one of the three key financial reports of a company CureVac N.V. (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Biotechnology industry

Issuer Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M germanyGermany
Acer Therapeutics Acer Therapeutics
ACER
- 2.71 % $ 14 M usaUSA
Agenus Agenus
AGEN
$ 3.27 -1.8 % $ 1.17 M usaUSA
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
$ 29.33 -2.98 % $ 1.7 B usaUSA
I-Mab I-Mab
IMAB
- - $ 866 M chinaChina
Akebia Therapeutics Akebia Therapeutics
AKBA
$ 1.26 -3.44 % $ 324 M usaUSA
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
$ 0.24 1.1 % $ 5.73 B britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B usaUSA
Aldeyra Therapeutics Aldeyra Therapeutics
ALDX
$ 5.49 0.52 % $ 330 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
- -10.17 % $ 12.2 K usaUSA
Alector Alector
ALEC
$ 2.26 -7.2 % $ 233 M usaUSA
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M franceFrance
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B usaUSA
Aligos Therapeutics Aligos Therapeutics
ALGS
$ 7.02 -0.21 % $ 451 M usaUSA
Alkermes plc Alkermes plc
ALKS
$ 29.32 -2.61 % $ 4.83 B irlandaIrlanda
Allogene Therapeutics Allogene Therapeutics
ALLO
$ 2.57 -7.73 % $ 403 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
$ 330.95 -0.59 % $ 43.4 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M britainBritain
Altimmune Altimmune
ALT
$ 4.2 -2.55 % $ 298 M usaUSA
ALX Oncology Holdings ALX Oncology Holdings
ALXO
$ 2.11 0.09 % $ 110 M usaUSA
Amgen Amgen
AMGN
$ 387.85 0.03 % $ 209 B usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
$ 20.22 -0.05 % $ 945 M usaUSA
Amarin Corporation plc Amarin Corporation plc
AMRN
$ 13.62 -1.3 % $ 5.55 B irlandaIrlanda
AIM ImmunoTech AIM ImmunoTech
AIM
$ 0.92 5.25 % $ 44.2 M usaUSA
AnaptysBio AnaptysBio
ANAB
$ 54.61 -0.8 % $ 1.55 B usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
$ 14.44 0.53 % $ 212 M usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
$ 75.31 1.91 % $ 1.45 B usaUSA
Annexon Annexon
ANNX
$ 5.38 -3.93 % $ 739 M usaUSA
Annovis Bio Annovis Bio
ANVS
$ 2.6 -2.99 % $ 23.5 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
- 1052.0 % $ 415 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
- 4.01 % $ 150 M canadaCanada
Adverum Biotechnologies Adverum Biotechnologies
ADVM
- - $ 86.2 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - russiaRussia
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
$ 20.53 -2.05 % $ 2.59 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
$ 0.78 -0.67 % $ 4.25 M chinaChina
AIkido Pharma AIkido Pharma
AIKI
- 1.93 % $ 17.4 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
- - $ 3.67 B usaUSA
Akouos Akouos
AKUS
- 0.23 % $ 488 M usaUSA
Aprea Therapeutics Aprea Therapeutics
APRE
$ 0.88 -3.71 % $ 3.18 M usaUSA
Aptevo Therapeutics Aptevo Therapeutics
APVO
$ 7.28 -0.55 % $ 2.01 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
- -0.23 % $ 916 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
- 3.16 % $ 1.9 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
$ 3.99 -0.15 % $ 346 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
$ 8.11 -1.44 % $ 219 M israelIsrael
Ardelyx Ardelyx
ARDX
$ 6.32 -3.54 % $ 1.52 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
- 10.36 % $ 9.8 M usaUSA
argenx SE argenx SE
ARGX
$ 762.51 -0.58 % $ 25 B niderlandNiderland